Presentation TCT 2012 Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway Presenter: Paul S. Rees, Derek J. Hausenloy, Derek M. Yellon January 03, 2012
News Conference News ASCOT: Unexplained Long-Term Mortality Benefit Found with Atorvastatin August 29, 2011
News Daily News Statin Users Have Better Outcomes After PCI for Stable CAD L.A. McKeown July 08, 2011
News Daily News Meta-analysis: Benefits of High-Dose Statins Confirmed Prior to PCI Jason Kahn April 11, 2011